2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with abt-737 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
Bjorge, JD; Cho, DC; Cohen, MB; Mier, JW; Zhu, S | 1 |
2 other study(ies) available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and abt-737
Article | Year |
---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells.
Topics: Apoptosis; Biphenyl Compounds; Blotting, Western; Carcinoma, Renal Cell; Caspase 3; Caspase 8; Cell Proliferation; Chromones; Drug Synergism; Enzyme Inhibitors; Humans; Kidney Neoplasms; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2013 |